Namenda/Memantine price-fixing, class action suit
Namenda/Memantine price-fixing, class action suit
File a claim to participate in the No Proof Required $56 Million Alzheimer's Namenda and Memantine Price-Fixing Class Action Lawsuit
Dementia / Alzheimer's Medication Class Action
"A $56 Million Class Action Settlement has been settled with pharmaceutical companies that manufacture and market certain Alzheimer's disease medications. The class action lawsuit alleged that pharma companies including Actavis, Merz, Teva, Dr. Reddy's, and Wockhardt conspired intentionally to keep generic versions of Alzheimer's medication off the shelves in order to drive up the cost of Namenda Alzheimer's medication. In the United States, the generic version of Namenda Alzheimer's disease drug is also known as Memantine."
Page contains a link to join the class action suit.